Cognitive effects of standard-dose chemotherapy in patients with cancer

Tim A. Ahles, Andrew Saykin

Research output: Contribution to journalArticle

150 Citations (Scopus)

Abstract

Adult cancer survivors have reported experiencing persistent changes in cognitive function following treatment with chemotherapy. Increasing evidence supports the hypothesis that standard-dose chemotherapy can produce cognitive deficits in a sub-group of adult cancer survivors. Although these cognitive changes tend to be subtle deficits in memory, concentration, and the ability to remain focused or organized, these alterations in cognitive ability can have a significant impact on patients' quality of life generally, and on meeting career and educational goals specifically. This manuscript reviews the literature relevant to the cognitive impact of standard-dose chemotherapy in adults, outlines methodological issues related to the study of cognitive functioning in people with cancer, and discusses future directions for research in this area.

Original languageEnglish (US)
Pages (from-to)812-820
Number of pages9
JournalCancer Investigation
Volume19
Issue number8
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Aptitude
Drug Therapy
Survivors
Neoplasms
Memory Disorders
Cognition
Quality of Life
Research
Therapeutics
Direction compound

Keywords

  • Chemotherapy-induced cognitive deficits
  • Neuropsychological assessment

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Cognitive effects of standard-dose chemotherapy in patients with cancer. / Ahles, Tim A.; Saykin, Andrew.

In: Cancer Investigation, Vol. 19, No. 8, 2001, p. 812-820.

Research output: Contribution to journalArticle

@article{9e645995a7404c1193d46d68e86927a4,
title = "Cognitive effects of standard-dose chemotherapy in patients with cancer",
abstract = "Adult cancer survivors have reported experiencing persistent changes in cognitive function following treatment with chemotherapy. Increasing evidence supports the hypothesis that standard-dose chemotherapy can produce cognitive deficits in a sub-group of adult cancer survivors. Although these cognitive changes tend to be subtle deficits in memory, concentration, and the ability to remain focused or organized, these alterations in cognitive ability can have a significant impact on patients' quality of life generally, and on meeting career and educational goals specifically. This manuscript reviews the literature relevant to the cognitive impact of standard-dose chemotherapy in adults, outlines methodological issues related to the study of cognitive functioning in people with cancer, and discusses future directions for research in this area.",
keywords = "Chemotherapy-induced cognitive deficits, Neuropsychological assessment",
author = "Ahles, {Tim A.} and Andrew Saykin",
year = "2001",
doi = "10.1081/CNV-100107743",
language = "English (US)",
volume = "19",
pages = "812--820",
journal = "Cancer Investigation",
issn = "0735-7907",
publisher = "Informa Healthcare",
number = "8",

}

TY - JOUR

T1 - Cognitive effects of standard-dose chemotherapy in patients with cancer

AU - Ahles, Tim A.

AU - Saykin, Andrew

PY - 2001

Y1 - 2001

N2 - Adult cancer survivors have reported experiencing persistent changes in cognitive function following treatment with chemotherapy. Increasing evidence supports the hypothesis that standard-dose chemotherapy can produce cognitive deficits in a sub-group of adult cancer survivors. Although these cognitive changes tend to be subtle deficits in memory, concentration, and the ability to remain focused or organized, these alterations in cognitive ability can have a significant impact on patients' quality of life generally, and on meeting career and educational goals specifically. This manuscript reviews the literature relevant to the cognitive impact of standard-dose chemotherapy in adults, outlines methodological issues related to the study of cognitive functioning in people with cancer, and discusses future directions for research in this area.

AB - Adult cancer survivors have reported experiencing persistent changes in cognitive function following treatment with chemotherapy. Increasing evidence supports the hypothesis that standard-dose chemotherapy can produce cognitive deficits in a sub-group of adult cancer survivors. Although these cognitive changes tend to be subtle deficits in memory, concentration, and the ability to remain focused or organized, these alterations in cognitive ability can have a significant impact on patients' quality of life generally, and on meeting career and educational goals specifically. This manuscript reviews the literature relevant to the cognitive impact of standard-dose chemotherapy in adults, outlines methodological issues related to the study of cognitive functioning in people with cancer, and discusses future directions for research in this area.

KW - Chemotherapy-induced cognitive deficits

KW - Neuropsychological assessment

UR - http://www.scopus.com/inward/record.url?scp=0035217019&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035217019&partnerID=8YFLogxK

U2 - 10.1081/CNV-100107743

DO - 10.1081/CNV-100107743

M3 - Article

C2 - 11768035

AN - SCOPUS:0035217019

VL - 19

SP - 812

EP - 820

JO - Cancer Investigation

JF - Cancer Investigation

SN - 0735-7907

IS - 8

ER -